title: Generic forms of low-molecular-weight heparins: some practical considerations.
abstract: This commentary briefly reviews the controversies of therapeutic and generic interchangeability, as they apply to the antithrombotic drug class called low-molecular-weight heparin (LMWH). Recommendations are prepared for the generic LMWH approval process by various regulatory bodies.
authors.affiliation: Burnaby Research, University of British Columbia, Vancouver, B.C., Canada. wendy@leong.com
authors.forename: Wendy
authors.initials: W
authors.lastname: Leong
authors.forename: Debra A
authors.initials: DA
authors.lastname: Hoppensteadt
mesh_terms: D000925:Anticoagulants / Q000592:standards; D017277:Drug Approval; D016568:Drugs, Generic / Q000592:standards*; D006495:Heparin, Low-Molecular-Weight / Q000592:standards*; D006801:Humans
chemical_list: D000925:Anticoagulants; D016568:Drugs, Generic; D006495:Heparin, Low-Molecular-Weight